Amaç: Uyuşturucu madde üretimi, ticareti ve kötüye kullanımı tüm dünyada ciddi bir halk sağlığı sorunudur. Kimyasal maddeler yasa dışı uyuşturucu üretiminde gerekli maddeler olup, uyuşturucu üreticileri sürekli yeni öncül maddeler ve teknikler geliştirmeye devam etmektedirler. Bu çalışmada, ülkemizde merdiven altı imalathanelerde yakalanan ve uyuşturucu madde imalatında kullanılan öncül kimyasalların çeşitleri ve sıklıkları araştırılmıştır. Gereç ve Yöntemler: Bu çalışmaya, Adli Tıp Kurumu 5. İhtisas Kuruluna 2009-2018 yılları arasındaki 10 yıllık dönemde gelen ve 5237 sayılı Türk Ceza Kanunu'nun 188/7. Maddesi kapsamında değerlendirilen merdiven altı imalathanelerde yakalanan öncül kimyasal maddelerin yer aldığı olgular dâhil edilmiştir. Olgular, yakalanan öncül kimyasal maddelerin yıllara, çeşitlerine, rastlanma sıklığına, coğrafi bölgelere, gönderen adli makama, birlikte yakalanan diğer uyuşturucu maddelerin cinslerine göre incelenmiştir. Bulgular: Çalışmamızda uyuşturucu imalatında kullanıldığı tespit edilen öncül kimyasal maddeler arasında sıklık sırasına göre aseton, efedrin/psödoefedrin, toluen, hidroklorik asit, sülfürik asit, iyot, asetik anhidrit yer almaktadır. Olguların %64'ünde bu kimyasal maddelerle birlikte uyuşturucu maddeler de saptanmıştır. Kimyasallara eşlik eden uyuşturucu maddeler arasında en sık amfetamin, metamfetamin, esrar, eroin, sentetik kannabinoidler, kokain ve metilen dioksi metamfetamin bulunmaktadır. Öncül madde son ürün ilişkisi incelendiğinde, en sık psödoefedrin/efedrin-metamfetamin, fenilaseton/benzil metil keton-amfetamin/metamfetamin ve asetik anhidrit-eroin birlikteliği tespit edilmiştir. Sonuç: Çalışmadan elde edilen veriler ışığında, ülkemizde merdiven altı imalathanelerde sıklıkla amfetamin ve metamfetamin imalatı yapıldığı söylenebilir. Öncül kimyasalların erişimine getirilecek kısıtlamalar, yasa dışı laboratuvarlarda uyuşturucu maddelerin imalatının önlenmesi açısından önem arz etmektedir.
Anahtar Kelimeler: Uyuşturucu madde imalatı; öncül kimyasal; merdiven altı imalathane
Objective: Drug production, trafficking and abuse are a serious public health problem all over the world. Chemical substances are necessary in the production of illicit drugs, and drug manufacturers continue to develop new precursors and techniques. In this study, the types and usage frequency of the chemicals used in the production of drugs in our country are investigated. Material and Methods: Cases involving chemical substances received by the 5th Specialized Board of the Council of Forensic Medicine in the ten years' period between the years of 2009-2018 and evaluated in the scope of article 188/7 of the Turkish Penalty Law, No. 5237 were included in this study. The cases were examined according to the years, types, frequency of occurrence of precursor chemicals, geographic regions, sending judicial authority, and the types of other drugs. Results: In our study, among the precursor chemicals used in the manufacture of drugs according to frequency are acetone, ephedrine/pseudoephedrine, toluene, hydrochloric acid, sulfuric acid, iodine and acetic anhydride respectively. Drugs were identified in 64% of these cases along with these chemicals. Prevailing among the drugs that accompany chemicals are amphetamine, methamphetamine, cannabis, heroin, synthetic cannabinoids, cocaine, and methylenedioxymethamphetamine. Pseudoephedrine/ephedrinemethamphetamine, phenylacetone/benzyl methyl ketone-amphetamine/ methamphetamine and acetic anhydride-heroin were found to be most common when the precursor end product relationship was examined. Conclusion: In the light of the data obtained from the study, it can be said that amphetamines and methamphetamine are frequently produced in clandestine laboratories in our country. Restrictions on access to precursor chemicals are important for the prevention of the manufacture of drugs in illegal laboratories.
Keywords: Drug production; precursor chemical; clandestine laboratory
- Pal R, Megharaj M, Kirkbride KP, Heinrich T, Naidu R. Biotic and abiotic degradation of illicit drugs, their precursor, and by-products in soil. Chemosphere. 2011;85(6):1002-9. [Crossref] [PubMed]
- Cunningham JK, Liu LM, Callaghan RC. Essential/precursor chemicals and drug consumption: impacts of US sodium permanganate and Mexico pseudoephedrine controls on the numbers of US cocaine and methamphetamine users. Addiction. 2016;111(11): 1999-2009. [Crossref] [PubMed]
- United States. Bureau for International Narcotics and Law Enforcement Affairs. International Narcotics Control Strategy Report: Drug and Chemical Control Vol. 1. [United States?]: CreateSpace; 2014. p.332.
- Freeman S, Alder JF. Arylethylamine psychotropic recreational drugs: a chemical perspective. Eur J Med Chem. 2002;37(7): 527-39. [Crossref]
- Skinner HF. Methamphetamine synthesis via hydriodic acid/red phosphorus reduction of ephedrine. Forensic Sci Int.1990;48(2):123-34. [Crossref]
- Callaghan RC, Cunningham JK, Victor JC, Liu LM. Impact of Canadian federal methamphetamine precursor and essential chemical regulations on methamphetamine-related acute- care hospital admissions. Drug Alcohol Depend. 2009;105(3):185-93. [Crossref] [PubMed]
- Al-Obaidi TA, Fletcher SM. Management of clandestine drug laboratories: need for evidence-based environmental health policies. Environ Health Prev Med. 2014;19(1):1-11. [Crossref] [PubMed] [PMC]
- Christian D. Forensic chemistry/controlled substances. In: Mozayani A, Noziglia C, eds. The Forensic Laboratory Handbook Procedures and Practice. 2nd ed. Totowa NJ: Humana Press; 2011. p.51-103. [Crossref] [PubMed]
- Power JD, Kavanagh P, McLaughlin G, Dowling G, Barry M, O'Brien J, et al. Forensic analysis of P2P derived amphetamine synthesis impurities: identification and characterization of indene by‐products. Drug Test Anal. 2017;9(3):446-52. [Crossref] [PubMed]
- T.C. İçişleri Bakanlığı Emniyet Genel Müdürlüğü Narkotik Suçlarla Mücadele Daire Başkanlığı. Türkiye Uyuşturucu Raporu 2018. Ankara: TUBİM; 2018. p.53.
- Avrupa Uyuşturucu ve Uyuşturucu Bağımlılığını İzleme Merkezi. Avrupa Uyuşturucu Raporu: Eğilimler ve Gelişmeler. Lüksemburg: Avrupa Toplulukları Resmi Yayınlar Bürosu; 2018. p.83.
- Caldicott DG, Pigou PE, Beattie R, Edwards JW. Clandestine drug laboratories in Australia and the potential for harm. Aust N Z J Public Health. 2005;29(2):155-62. [Crossref] [PubMed]
- EMCDDA I. European Drug Report 2016: Trends and Developments. Luxembourg: Publications Office of the European Union; 2016. p.71.
- EMCDDA E. EU Drug Markets Report: Strategic Overview. Lisbon: European Monitoring Centre for Drugs and Drug Addiction; 2016. p.32.
- Mounteney J, Griffiths P, Cunningham A, Evans-Brown M, Ferri M, Hedrich D, et al. Continued signs of resilience in the European drug market: Highlights from the EMCDDA's 2016 European drug report. Drugs: Education, Prevention and Policy. 2016;23(6):492-5. [Crossref]
- Hauser FM, Rößler T, Hulshof JW, Weigel D, Zimmermann R, Pütz M. Identification of specific markers for amphetamine synthesised from the pre‐precursor APAAN following the Leuckart route and retrospective search for APAAN markers in profiling databases from Germany and the Netherlands. Drug Test Anal. 2018;10(4):671-80. [Crossref] [PubMed]
- Crawford C, Lombardo S, Thomson F, Visintin C, Wright C. United Kingdom Drug Situation 2015 Edition: Annual Report to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) 2015. London UK: Department of Health London; 2015. p.190.
- EMCDDA. Drug Trafficking Penalties Across the European Union: A Survey of Expert Opinion. EMCDDA Lisbon, Portugal; 2017. p.32.
- Krawczyk W, Kunda T, Perkowska I, Dudek D. Impurity profiling/comparative analyses of samples of 1-phenyl-2-propanone. Bull Narc. 2005;57(1-2):33-62.
- Roman-Urrestarazu A, Robertson R, Yang J, McCallum A, Gray C, McKee M, et al. European Monitoring Centre for Drugs and Drug Addiction has a vital role in the UK's ability to respond to illicit drugs and organised crime. BMJ. 2018;362:k4003. [Crossref] [PubMed]
- Merz F. [United Nations Office on Drugs and Crime: World Drug Report 2017]. SIRIUS-Zeitschrift für Strategische Analysen. 2018;2 (1):85-6. [Crossref]
- en Europol E. EU Drugs Market Report: In-Depth Analysis. Luxembourg: Publications Office of the European Union; 2016. p.188.
- Power JD, Kavanagh P, McLaughlin G, Barry M, Dowling G, Brandt SD. 'APAAN in the neck'-A reflection on some novel impurities found in seized materials containing amphetamine in Ireland during routine forensic analysis. Drug Testing And Analysis. 2017;9(7): 966-76. [Crossref] [PubMed]
.: Process List